The Role of TVSG and HS in Determining Endometrial Pathologies
Study Details
Study Description
Brief Summary
Although hysteroscopy (HS) and transvaginal ultrasonography (TVSG) are methods in the diagnosis of AUB, there is some suspicion about their efficacy. The aim of this study was to determine the efficacy and safety of HS and TVSG on diagnosing abnormal uterine bleeding(AUB) .216 women admitted to the investigators clinic (Sisli Ethal Training and Research Hospital, Obstetrics and Gynecology Department Obstetrics Service ) between 21-51 years of age. These patients were divided into two groups; menopause (71women) and pre-menopause (145 women). HS and endometrial sampling were performed both groups after TVSG.The success of these methods was assessed by kappa analysis
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Transvaginal ultrasound Transvaginal ultrasound was applied 216 women with abnormal uterine bleeding.The transvaginal ultrasound diagnoses were compared with the received endometrial samples. |
Device: Transvaginal ultrasound
|
Other: Hysteroscopy Hysteroscopy was also performed under general anesthesia.Hysteroscopy was performed by a single operator (NNY).The operator and two supervising endoscopists were blinded to the ultrasound results.After the hysteroscopy, endometrial sampling was also done. The diagnoses were compared with the received endometrial samples. |
Device: Hysteroscopy
|
Outcome Measures
Primary Outcome Measures
- accuracy of diagnostic performance transvaginal ultrasonography and hysteroscopy [up to 12 month]
The main outcome variable of the study was accuracy of diagnostic performance of transvaginal ultrasonography and hysteroscopy in premenopausal and menopausal women with abnormal uterin bleeding .
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients who have no history of hysteroscopy and curettage,
-
patients who have no history of ovulatory dysfunction
-
women who have active vaginal bleeding.
Exclusion Criteria:
-
presence of genital infections/PID
-
presence of pregnancy
-
presence of vaginal or cervical pathology causing vaginal bleeding
-
women who are receiving hormonal treatment (COC/HRT)
-
patients formerly diagnosed with endometrial pathology
-
patients having coagulopathy
-
women who are using intrauterine device.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Sisli Hamidiye Etfal Training and Research Hospital
Investigators
- Study Director: Nefise Nazlı YENIGUL, MD, Sisli Etfal Research and Training hospital, Obstetrics and gynecology department Istanbul, Marmara Turkey
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 349